证券日报网讯12月2日，金埔园林（301098）在互动平台回答投资者提问时表示，截至2025年11月28日 公司合并普通账户和融资融券信用账户的在册股东总数为10600户。 ...

债券受托管理人： 股票简称：金埔园林 股票代码：301098 债券简称：金埔转债 债券代码：123198 长江证券承销保荐有限公司 关于金埔园林股份有限公司向不特定对象 发行可转换公司债券的临时受托管理事务 报告 金埔园林股份有限公司向不特定对象发行可转换公司债券 2025 年度第 6 次临时受托管理事务报告 中国（上海）自由贸易试验区世纪大道1198号28层 2025 年 12 月 金埔园林股份有限公司向不特定对象发行可转换公司债券 2025 年度第 6 次临时受托管理事务报告 声 明 长江证券承销保荐有限公司（以下简称"长江保荐"、"保荐人"或"受托管 理人"）编制本报告的内容及信息均来源于发行人相关信息披露文件、金埔园林 股份有限公司（以下简称"金埔园林"、"发行人"或"公司"）提供的证明文件 及第三方中介机构出具的专业意见。长江保荐对报告中所包含的相关引述内容和 信息未进行独立验证，也不就该等引述内容和信息的真实性、准确性和完整性做 出任何保证或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为长江保荐所作的承诺 或 ...

Group 1: Storage Market Dynamics - The storage spot market is experiencing strong demand, leading to continued price increases for finished products, despite high prices [1] - Customers with low inventory levels are gradually accepting new pricing agreements, providing manufacturers with confidence to raise prices [1] - The significant price increases are affecting retail markets, with online and offline retailers raising prices for memory modules and SSDs, potentially reducing consumer purchasing willingness [1] Group 2: DRAM Industry Forecast - According to TrendForce, the DRAM industry revenue is expected to grow by 30.9% quarter-on-quarter in Q3 2025, reaching $41.4 billion due to rising contract prices and increased shipment volumes [1] - The fourth quarter is anticipated to see a significant increase in contract prices, with conventional DRAM prices expected to rise by 45%-50% [1] - The overall contract prices for conventional DRAM and HBM combined are projected to increase by 50%-55% [1] Group 3: Medical Device Market Growth - The Chinese medical device market is projected to reach ¥1.22 trillion by 2025, with over 33,000 production enterprises expected by the end of 2024, marking a 27.8% increase from the end of the 13th Five-Year Plan [2] - The industry is transitioning from "catching up" to "running alongside and leading," supporting the "Healthy China" strategy [2] Group 4: Flu Season Impact on Pharmaceuticals - The flu season has started early in China, with a 237% increase in sales of Oseltamivir over the past week, and a 180% increase for Maviral [2] - The peak of the flu season is expected between mid-December and early January [2] Group 5: Cinema Industry Growth - As of October 2023, China has added 233 cinemas and 1,588 screens, totaling 15,438 operating cinemas and 92,556 screens nationwide [3] - County-level cinemas account for 21.06% of the total, while town cinemas make up 18.01% [3] Group 6: Innovations in Medical Technology - Novo Nordisk's Kyinsu, the world's first weekly insulin and GLP-1 receptor agonist combination, has been approved in the EU for adults with type 2 diabetes [3] - This innovation represents a significant advancement in diabetes treatment options [3] Group 7: Corporate Developments - Allianz Partners plans to lay off 1,500 to 1,800 employees over the next 12-18 months, primarily in call center roles due to automation [5] - Novartis announced plans to cut up to 550 jobs in Switzerland by the end of 2027 as part of production adjustments [5]

Group 1 - Aolide plans to raise no more than 300 million yuan through a simplified procedure for issuing shares to specific targets, with net proceeds allocated to the production base project for OLED display core materials and to supplement working capital [1] - Wanbang's subsidiary has obtained a 10-year exclusive agency for sildenafil oral suspension, which is suitable for patients with swallowing difficulties [2] - Titan Technology and its affiliate plan to jointly invest in increasing capital for its subsidiary, Micro Detection, raising its registered capital from 10 million yuan to 50 million yuan [3] Group 2 - Jindike will not issue new batches of quadrivalent influenza virus split vaccine this year, having produced approximately 1.56 million doses [4] - Aladdin intends to purchase 35% equity of Youke for 61.25 million yuan, funded by its own or raised capital [5] - Gujia Home's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] Group 3 - Honghe Technology's application for a private placement of A-shares has been approved by the China Securities Regulatory Commission [9] - Guangdian Yuntong has won contracts totaling 308 million yuan for the construction of an artificial intelligence application pilot base [10] - Shanghai Mechanical plans to repurchase B-shares worth no more than 278 million yuan [11] Group 4 - Weiling Co. is planning a change of control, with shares representing 7.76% of the total being transferred [14] - Jiugang Hongxing intends to invest 200 million yuan to establish a wholly-owned subsidiary focusing on high-quality special steel materials [16] - Zhongjian Technology has submitted an application for H-share listing [17] Group 5 - Sainuo Medical has received registration approval for its coronary product in Pakistan [18] - Huafeng Aluminum plans to acquire 100% equity of Huafeng Puen for 100 million yuan [20] - Fuda Co. intends to establish a wholly-owned subsidiary with an investment of 30 million yuan [22] Group 6 - Su Yan Jingshen's application for a private placement of shares has been approved by the Shanghai Stock Exchange [24] - Zhongchuang Co. has set the inquiry transfer price at 25.75 yuan per share [25] - Jinpu Garden has had a lawsuit involving 26.557 million yuan accepted by the court [29] Group 7 - ICBC has approved the appointment of Zhao Guid as vice president [30] - Betta Pharmaceuticals has had its drug registration application for ensartinib accepted [32] - Times New Materials plans to invest 6 million euros to establish a wholly-owned subsidiary in Serbia [34] Group 8 - China State Construction has appointed Chen Yong as vice president [36] - Dayang Electric plans to invest 10 million yuan to establish an industrial fund [38] - Advanced Digital has appointed Liu Zhigang as deputy general manager [39] Group 9 - Tianqi Co. plans to transfer 7% equity of Youqi Intelligent for 130 million yuan [40] - Xinguo has submitted an application for H-share issuance and listing [42] - Jinhongshun's shareholder has terminated a share reduction plan [43] Group 10 - Wanrun Co.'s actual controller plans to increase shareholding between 365 million yuan and 730 million yuan [44] - Suzhou High-tech plans to sell 47% equity of its medical device subsidiary for 604 million yuan [45] - Huayou Cobalt's subsidiary has signed a product supply agreement with Yiwei Lithium Energy for approximately 127,800 tons of materials [47] Group 11 - China Communications has won 10 important projects totaling approximately 2.539 billion yuan [49] - Nopushin plans to raise no more than 1.45 billion yuan through a private placement [50] - Yun Aluminum plans to acquire minority stakes in three subsidiaries for a total of 2.267 billion yuan [51] Group 12 - Xiamen Tungsten plans to establish a 500 million yuan merger fund with multiple parties [52] - Aotewei has signed a contract worth approximately 700 million yuan [54] - Hemai Co.'s shareholders plan to reduce their holdings by no more than 3% [56]

| 证券代码：301098 | 证券简称：金埔园林 | 公告编号：2025-142 | | --- | --- | --- | | 债券代码：123198 | 债券简称：金埔转债 | | 金埔园林股份有限公司 关于公司涉及重大诉讼的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1.案件所处的诉讼阶段：法院已受理，尚未正式开庭 2.上市公司所处的当事人地位：原告 3.涉案的金额：2,655.70 万元 4.对上市公司损益产生的影响：因本案尚未正式开庭，目前暂时无法预计本 案对公司本期及期后利润的具体影响。公司将根据诉讼进展情况及时履行信息披 露义务，敬请广大投资者理性投资，注意投资风险。 一、本次诉讼受理的基本情况 金埔园林股份有限公司（以下简称"公司"或"原告"）于 2025 年 11 月 24 日收到淮安市淮阴区人民法院下发的《受理案件通知书》《交纳诉讼费用通 知书》【（2025）苏 0804 民初 11165 号】，诉讼受理的基本情况如下： （一）诉讼理由 2019 年 9 月 12 日，原告、被告一签订《徐溜镇涵洞村特色田园乡村（农民 ...

Core Insights - The company Jinpu Garden (301098) reported that as of November 20, 2025, the total number of registered shareholders in its combined ordinary and margin trading accounts is 10,816 [1] Summary by Categories - **Company Information** - Jinpu Garden has a total of 10,816 registered shareholders in its combined ordinary and margin trading accounts as of the specified date [1]

Core Points - Jinpu Garden (301098) announced the election of Liu Yanli as the employee representative director of the fifth board of directors during the employee representative meeting scheduled for November 17, 2025 [1] Company Summary - The company will hold an employee representative meeting on November 17, 2025 [1] - Liu Yanli has been elected as the employee representative director [1]

| 证券代码：301098 | 证券简称：金埔园林 | 公告编号：2025-140 | | --- | --- | --- | | 债券代码：123198 | 债券简称：金埔转债 | | 金埔园林股份有限公司 关于召开 2025 年第四次临时股东会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 金埔园林股份有限公司（以下简称"公司"）于 2025 年 11 月 20 日召开第五 届董事会第二十九次会议，审议通过了《关于召开 2025 年第四次临时股东会的 议案》，公司决定于 2025 年 12 月 9 日（星期二）下午 15:00 以现场表决与网络 投票相结合的方式召开公司 2025 年第四次临时股东会（以下简称"股东会"）， 根据有关规定，现将会议的有关事项通知如下： 一、召开会议的基本情况 1.会议届次：2025 年第四次临时股东会 2.会议召集人：公司第五届董事会 3.会议召开的合法、合规性：本次股东会的召集程序符合《中华人民共和国 公司法》《中华人民共和国证券法》《深圳证券交易所创业板股票上市规则》等 有关法律法规及《公司章程》的规定 4.会议 ...

| 证券代码：301098 | 证券简称：金埔园林 | 公告编号：2025-138 | | --- | --- | --- | | 债券代码：123198 | 债券简称：金埔转债 | | 金埔园林股份有限公司 表决结果：同意 9 票，反对 0 票，弃权 0 票。 2.审议通过《关于召开公司 2025 年第四次临时股东会的议案》 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的《关于召 开 2025 年第四次临时股东会的通知》。 第五届董事会第二十九次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 金埔园林股份有限公司（以下简称"公司"）于 2025 年 11 月 20 日在南京市 江宁区东山街道润麒路 70 号公司会议室以现场结合通讯方式召开了第五届董事 会第二十九次会议。会议通知于 2025 年 11 月 17 日以电子邮件形式送达公司全 体董事和高级管理人员。本次会议应出席董事 9 名，实际出席会议董事 9 名。本 次会议由董事长王宜森先生主持，高级管理人员列席了会议。本次会议的召开和 表决 ...

| 证券代码：301098 | 证券简称：金埔园林 | 公告编号：2025-139 | | --- | --- | --- | | 债券代码：123198 | 债券简称：金埔转债 | | 关于非独立董事辞职、选举职工代表董事 并调整董事会提名与薪酬考核委员会委员的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、非独立董事辞任的情况 金埔园林股份有限公司（以下简称"公司"）董事会近日收到公司非独立董事 刘殿华先生的辞职报告。因个人原因，刘殿华先生申请辞去公司非独立董事职务 及董事会提名与薪酬考核委员会委员职务。辞去上述职务后仍在公司担任其他职 务。 刘殿华先生原定任期届满之日为 2027 年 1 月 16 日，其离任自辞职报告送达 公司董事会之日起生效。刘殿华先生的辞任不会导致董事会成员低于法定人数， 不会影响公司董事会的正常运行，亦不会对公司的规范运作和日常运营产生不利 影响。 截至本公告披露日，刘殿华先生持有公司股份 1,125,000 股，占公司总股本 0.61%。刘殿华先生承诺将继续遵守《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市 ...